(Q35246938)

7 August 2017

title

Diverse potential of beta-lactamase inhibitors to induce class I enzymes (English)

1 reference

7 August 2017

Weber DA

1

1 reference

7 August 2017

Sanders CC

series ordinal

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

7 August 2017

number of pages

3

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

7 August 2017

volume

34

1 reference

7 August 2017

issue

1

1 reference

7 August 2017

page(s)

156-158

1 reference

In vitro antagonism of beta-lactam antibiotics by cefoxitin

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171539

Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171539

Antagonism of carbenicillin and cefamandole by cefoxitin in treatment of experimental infections in mice

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171539

In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171539

Chromosomal cephalosporinases responsible for multiple resistance to newer beta-lactam antibiotics

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171539

Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171539

Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171539

Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171539

Emergence of Resistance to Cefamandole: Possible Role of Cefoxitin-Inducible Beta-Lactamases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171539

The effects of clavulanic acid and sulbactam on beta-lactamase biosynthesis

12 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2327752

12 December 2020

inferred from PubMed ID database lookup

Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2327752

12 December 2020

inferred from PubMed ID database lookup

Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2327752

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.34.1.156

1 reference

7 August 2017

1 reference

7 August 2017

1 reference